Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-000967
Filing Date
2013-01-31
Accepted
2013-01-31 17:01:03
Documents
13
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q unigene_10q-093012.htm 10-Q 1018114
2 EXHIBIT 10.19 ex10-19.htm EX-10.19 37226
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 18834
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 18870
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 8326
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 8604
13 ex10-190.jpg GRAPHIC 10248
  Complete submission text file 0001437749-13-000967.txt   7845164

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS ugne-20120930.xml EX-101.INS 1192264
8 EXHIBIT 101.SCH ugne-20120930.xsd EX-101.SCH 72204
9 EXHIBIT 101.CAL ugne-20120930_cal.xml EX-101.CAL 46400
10 EXHIBIT 101.DEF ugne-20120930_def.xml EX-101.DEF 401578
11 EXHIBIT 101.LAB ugne-20120930_lab.xml EX-101.LAB 469483
12 EXHIBIT 101.PRE ugne-20120930_pre.xml EX-101.PRE 401776
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16005 | Film No.: 13563359
SIC: 2833 Medicinal Chemicals & Botanical Products